【ChiCTR2000032336】IS PREDICTION OF LOCAL RECURRENCE POSSIBLE IN PAGET’S DISEASE OF THE BREAST?
ChiCTR2000032336
结束
/
/
/
2020-04-26
/
/
Mammary Paget'S disease
IS PREDICTION OF LOCAL RECURRENCE POSSIBLE IN PAGET’S DISEASE OF THE BREAST?
IS PREDICTION OF LOCAL RECURRENCE POSSIBLE IN PAGET’S DISEASE OF THE BREAST?
Mammary Paget disease of the breast is rare form of breast cancer. Recent trends in the management has changed from mastectomy to breast conserving surgery, its safety is still controversial. The study aimed to predict the patients prone to local recurrence, and to find out the answer to the question of who should be a candidate for breast conserving surgery.
队列研究
回顾性研究
non randomized
None
own funding
/
69
/
2020-04-25
2020-04-25
/
Between January 2007 and December 2017, an institutional database search was done retrospectively to select patients with a diagnosis of mammary PD and underwent surgery in our hospital. Sixty nine women operated for a stage I to III breast cancer were enrolled in this study;
请登录查看Eleven patients with a synchronous other primary malignancy or who did not come to regular follow-up, were excluded.;
请登录查看SBU, Ankara Oncology Education and Research Hospital
/
SBU, Ankara Oncology Education and Research Hospital的其他临床试验
土耳其安卡拉肿瘤学教育和研究医院的其他临床试验
最新临床资讯
-
飞眸医疗首例人体临床试验(FIH)成功开展,国产飞秒屈光设备竞逐540亿屈光市场
动脉网-最新2026-09-10
-
和铂医药:超长效靶向TSLP抗体哮喘二期临床取得阳性结果,三期临床已启动
医药笔记2026-09-09
-
医药笔记2026-09-09
-
医药笔记2026-09-09
-
医药笔记2026-09-09
-
医药笔记2026-09-09
-
动脉网-最新2026-09-09
-
药明康德2026-09-09
-
一度医药2026-09-08
-
阿斯利康中国2026-09-08
全球药物研发中心
全球研发数据与行业前沿情报
-
2026-09-26
-
2026-09-26
-
2026-09-26
-
摩熵咨询 20 8
-
摩熵咨询 20 11
-
摩熵咨询 34 56
-
颁布机构:国家药品监督管理局 2026-09-10
-
颁布机构:四川省经济和信息化厅、中共四川省委军民融合发展委员会办公室、四川省教育厅、四川省科学技术厅、四川省人力资源和社会保障厅、四川省卫生健康委员会、四川省医疗保障局、四川省中医药管理局、四川省药品监督管理局 2026-08-04
-
颁布机构:国家医保局 2026-07-31
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
-
2026-09-28
-
2026-09-26
-
2026-09-26
-
摩熵咨询 35 71
-
摩熵咨询 28 60
-
摩熵咨询 34 42
-
颁布机构:国家市场监督管理总局 2026-09-18
-
颁布机构:国家市场监督管理总局 2026-09-17
-
颁布机构:国家市场监督管理总局 2026-08-10
